Modifying factors and phenotypic diversity in Wilson's disease
1Department of Physiology, Johns Hopkins University, Baltimore, Maryland.
Annals of the New York Academy of Sciences
|April 8, 2014
Summary
Wilson's disease (WD) is a genetic disorder of copper metabolism due to ATP7B gene mutations. Understanding genetic and metabolic factors, like cholesterol, is key to explaining varied patient symptoms and disease progression.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Wilson's disease (WD) is a human genetic disorder affecting copper homeostasis.
- It is caused by mutations in the copper-transporting ATPase ATP7B gene.
- WD leads to copper accumulation in the liver and brain, causing hepatic pathology and diverse clinical presentations.
Purpose of the Study:
- To investigate factors contributing to the phenotypic variability observed in Wilson's disease.
- To explore the role of genetic polymorphisms and altered copper metabolism in disease manifestation.
- To identify potential biomarkers for disease progression using transcriptomic analysis.
Main Methods:
- Analysis of mutations in the ATP7B gene and their impact on protein function.
- Transcriptomic profiling in Atp7b(-/-) mice to identify changes in gene expression.
- Investigation of copper accumulation's effect on lipid and cholesterol metabolism.
Main Results:
- WD-causing mutations result in a spectrum of ATP7B protein alterations affecting stability, activity, and trafficking.
- Abnormal copper distribution in the liver of Atp7b(-/-) mice induces significant changes in the transcriptome.
- Copper accumulation impacts lipid and cholesterol metabolism, suggesting their role as modifying factors in WD.
Conclusions:
- Phenotypic variability in WD is influenced by mutation type, genetic polymorphisms, and metabolic factors.
- Transcriptomic profiles in mouse models may aid in defining disease progression.
- Lipid and cholesterol metabolism are important modifiers of Wilson's disease in both mice and humans.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:16Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
01:27Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
01:33Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
02:27Background and Environment Affect Phenotype
5.8K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
5.8K